阿尔法发射核素市场：依放射性核种类型、应用划分 - 2024-2030 年全球预测

预计2023年α发射核种市场规模为8.8695亿美元，2024年将达10.6244亿美元，2030年将达32.1195亿美元，复合年增长率为20.18%。

全球α发射核素市场

FPNV定位矩阵

FPNV定位矩阵对于评估α发射核种市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对 α 发射核素市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-α发射核种市场的市场规模和预测是多少？

2-在阿尔法发射核素市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3-α发射核种市场的技术趋势和法律规范是什么？

4-α发射核种市场主要供应商的市场占有率是多少？

5-进入α发射核种市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 心臟病和癌症患者数量增加
    • 提高人们对目标阿尔法发送器潜在好处的认识
    • α发射核素在工业的新兴用途
  • 抑制因素
    • α发射核素的生产成本较高。
  • 机会
    • 癌症治疗新临床试验活动的出现
    • 持续进行研发活动，探索α发射核素的新应用领域
  • 任务
    • α发射核素的复杂处理与安全性问题
• 市场区隔分析
• 市场趋势分析
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范

第六章以放射性核种类型分類的α发射核素市场

• 锕225
• 镅-241
• 砈-211
• 钸239
• 镭226
• 铀238

第七章 阿尔法发射核素市场：依应用分类

• 工业的
• 药品
  • 骨转移
  • 内分泌肿瘤
  • 卵巢癌
  • 胰臟癌
  • 摄护腺癌

第八章美洲阿尔法核素市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太地区α排放核素市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章 欧洲、中东和非洲α排放核素市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争形势

• FPNV定位矩阵
• 市场占有率分析：主要企业
• 主要企业竞争情境分析

第12章竞争产品组合

• 主要公司简介
  • Actinium Pharmaceuticals, Inc.
  • Alpha Tau Medical Ltd.
  • Bayer AG
  • Bracco SpA
  • Cardinal Health, Inc.
  • Eckert & Ziegler
  • Fusion Pharmaceuticals Inc.
  • Ionetix Corporation
  • Niowave Inc.
  • Orano Group
  • RadioMedix, Inc.
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited
• 主要产品系列

第十三章附录

• 讨论指南
• 关于许可证和定价

[185 Pages Report] The Alpha Emitters Market size was estimated at USD 886.95 million in 2023 and expected to reach USD 1,062.44 million in 2024, at a CAGR 20.18% to reach USD 3,211.95 million by 2030.

Global Alpha Emitters Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alpha Emitters Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alpha Emitters Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alpha Emitters Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Alpha Tau Medical Ltd., Bayer AG, Bracco S.p.A., Cardinal Health, Inc., Eckert & Ziegler, Fusion Pharmaceuticals Inc., Ionetix Corporation, Niowave Inc., Orano Group, RadioMedix, Inc., Siemens Healthineers, and Telix Pharmaceuticals Limited.

Market Segmentation & Coverage

This research report categorizes the Alpha Emitters Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Radionuclide Type
  • Actinium-225
  • Americium-241
  • Astatine-211
  • Plutonium-239
  • Radium-226
  • Uranium-238
• Application
  • Industrial
  • Medical
    • Bone Metastasis
    • Endocrine Tumors
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alpha Emitters Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alpha Emitters Market?

3. What are the technology trends and regulatory frameworks in the Alpha Emitters Market?

4. What is the market share of the leading vendors in the Alpha Emitters Market?

5. Which modes and strategic moves are suitable for entering the Alpha Emitters Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Alpha Emitters Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing number of patients with cardiac and cancer ailments
    • 5.1.1.2. Increased awareness of potential benefits of targeted alpha emitter
    • 5.1.1.3. Emerging use of alpha emitters in industrial sectors
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of production of alpha emitters
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging new clinical trial activities for cancer treatment
    • 5.1.3.2. Ongoing R&D activities for exploring new application areas of alpha emitters
  • 5.1.4. Challenges
    • 5.1.4.1. Complex handling and safety hazards of alpha emitters
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Alpha Emitters Market, by Radionuclide Type

• 6.1. Introduction
• 6.2. Actinium-225
• 6.3. Americium-241
• 6.4. Astatine-211
• 6.5. Plutonium-239
• 6.6. Radium-226
• 6.7. Uranium-238

7. Alpha Emitters Market, by Application

• 7.1. Introduction
• 7.2. Industrial
• 7.3. Medical
  • 7.4.1. Bone Metastasis
  • 7.4.2. Endocrine Tumors
  • 7.4.3. Ovarian Cancer
  • 7.4.4. Pancreatic Cancer
  • 7.4.5. Prostate Cancer

8. Americas Alpha Emitters Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Alpha Emitters Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Alpha Emitters Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Actinium Pharmaceuticals, Inc.
  • 12.1.2. Alpha Tau Medical Ltd.
  • 12.1.3. Bayer AG
  • 12.1.4. Bracco S.p.A.
  • 12.1.5. Cardinal Health, Inc.
  • 12.1.6. Eckert & Ziegler
  • 12.1.7. Fusion Pharmaceuticals Inc.
  • 12.1.8. Ionetix Corporation
  • 12.1.9. Niowave Inc.
  • 12.1.10. Orano Group
  • 12.1.11. RadioMedix, Inc.
  • 12.1.12. Siemens Healthineers
  • 12.1.13. Telix Pharmaceuticals Limited
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. ALPHA EMITTERS MARKET RESEARCH PROCESS
• FIGURE 2. ALPHA EMITTERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ALPHA EMITTERS MARKET DYNAMICS
• FIGURE 7. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2030 (%)
• FIGURE 8. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ALPHA EMITTERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 6. ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ALPHA EMITTERS MARKET SIZE, BY ASTATINE-211, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ALPHA EMITTERS MARKET SIZE, BY PLUTONIUM-239, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ALPHA EMITTERS MARKET SIZE, BY RADIUM-226, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ALPHA EMITTERS MARKET SIZE, BY URANIUM-238, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ALPHA EMITTERS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 16. ALPHA EMITTERS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. ALPHA EMITTERS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. ALPHA EMITTERS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. ALPHA EMITTERS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. ALPHA EMITTERS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 148. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 149. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. ALPHA EMITTERS MARKET LICENSE & PRICING